Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,690,137
-$20,530,618 QoQ
Shares Held
152,129
-89.2% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#59
of 230 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Derivatives in RCUS
reported options exposure · as of Dec 31, 2020CallValue
$6,160,308
CallShares
237,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $494,895,363 across 45 Biotechnology names. RCUS ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
233,171 | $62,191,369 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
219,596 | $53,750,512 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
160,768 | $38,740,264 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
308,385 | $29,219,478 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
143,222 | $26,822,616 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
253,358 | $18,870,103 | |
| 7 | CYTK |
Cytokinetics Inc
|
191,686 | $16,329,730 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
29,313 | $15,739,615 |
All Filings in RCUS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,690,137 | 152,129 | Shares | Defined | 2026-08-14 | |
| 2023-09-30 | $25,220,755 | 1,405,056 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,536,687 | 1,405,056 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $28,453,433 | 1,559,947 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $55,903,975 | 2,703,287 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $88,505,375 | 3,383,233 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $84,799,245 | 3,346,458 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $108,282,675 | 3,431,010 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $138,852,974 | 3,431,010 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $119,639,318 | 3,431,010 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $96,062,219 | 3,498,260 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $98,231,140 | 3,498,260 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,160,308 | 237,300 | Call | Defined | 2021-02-19 | |
| 2020-12-31 | $87,575,021 | 3,373,460 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $43,483,014 | 2,536,932 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $4,113,600 | 240,000 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $42,938,273 | 1,735,581 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $11,236,012 | 809,511 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||